We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$67.4M
Cap. Flow
+$120M
Cap. Flow %
5.45%
Top 10 Hldgs %
16.34%
Holding
918
New
52
Increased
475
Reduced
305
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 12.03%
2 Healthcare 10.7%
3 Financials 10.61%
4 Industrials 5.55%
5 Consumer Discretionary 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
501
Sherwin-Williams
SHW
$88.5B
$856K 0.04%
+2,517
New +$939K
HNI icon
502
HNI Corp
HNI
$3.57B
$852K 0.04%
16,916
+2,980
+21% +$160K
EFR
503
Eaton Vance Senior Floating-Rate Fund
EFR
$318M
$850K 0.04%
66,380
+13,609
+26% +$175K
CIFR icon
504
Cipher Digital
CIFR
$7.14B
$849K 0.04%
182,897
+37,162
+25% +$211K
REVG
505
DELISTED
REV Group
REVG
$840K 0.04%
26,364
+284
+1% +$8.44K
SNA icon
506
Snap-on
SNA
$21.3B
$837K 0.04%
2,465
-441
-15% -$149K
AIR icon
507
AAR Corp
AIR
$5.86B
$835K 0.04%
13,625
+3,737
+38% +$239K
IRWD icon
508
Ironwood Pharmaceuticals
IRWD
$711M
$832K 0.04%
187,773
+16,962
+10% +$68.8K
OHI icon
509
Omega Healthcare
OHI
$13.8B
$832K 0.04%
21,971
+363
+2% +$14.5K
AMBA icon
510
Ambarella
AMBA
$3.64B
$822K 0.04%
11,299
-16
-0.1% -$1.02K
UTHR icon
511
United Therapeutics
UTHR
$22.1B
$821K 0.04%
2,327
-1,959
-46% -$720K
ANF icon
512
Abercrombie & Fitch
ANF
$5.24B
$819K 0.04%
5,482
+519
+10% +$75.8K
CCCC icon
513
C4 Therapeutics
CCCC
$428M
$818K 0.04%
227,147
+34,783
+18% +$173K
ROCK icon
514
Gibraltar Industries
ROCK
$1.48B
$811K 0.04%
13,765
-40
-0.3% -$2.73K
CDRE icon
515
Cadre Holdings
CDRE
$1.46B
$808K 0.04%
25,003
+5,639
+29% +$200K
SPOK icon
516
Spok Holdings
SPOK
$239M
$806K 0.04%
50,221
+12,471
+33% +$198K
LDOS icon
517
Leidos
LDOS
$17.7B
$801K 0.04%
5,559
+680
+14% +$113K
HPE icon
518
Hewlett Packard
HPE
$72B
$800K 0.04%
+37,491
New +$791K
SMDV icon
519
ProShares Russell 2000 Dividend Growers ETF
SMDV
$705M
$797K 0.04%
11,776
+321
+3% +$22.8K
BA icon
520
Boeing
BA
$184B
$782K 0.04%
4,419
+1,421
+47% +$223K
ZETA icon
521
Zeta Global
ZETA
$7.32B
$782K 0.04%
43,477
+15,068
+53% +$381K
VLO icon
522
Valero Energy
VLO
$93.3B
$777K 0.04%
6,342
+1,505
+31% +$201K
KR icon
523
Kroger
KR
$34.5B
$777K 0.04%
12,706
-2,117
-14% -$124K
PRCT icon
524
Procept Biorobotics
PRCT
$1.31B
$775K 0.04%
9,624
+3,702
+63% +$316K
HII icon
525
Huntington Ingalls Industries
HII
$12.9B
$773K 0.04%
4,090
+674
+20% +$146K

Similar funds

Hennion & Walsh Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Hennion & Walsh Asset Management held 918 positions worth $2.21B, up 3.1% from $2.14B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management deployed $120M of net new capital in Q4 2024, opening 52 new positions and adding to 475 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 118,596 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan US Quality Factor ETF, an estimated $23.8M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2024 buy was Vanguard Morningstar Value ETF: 118,596 shares worth $20.1M.
  • Hennion & Walsh Asset Management added most to ProShares S&P 500 High Income ETF in Q4 2024, an estimated $7.79M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2024 reduction was JPMorgan US Quality Factor ETF, cutting an estimated $23.8M.
  • Hennion & Walsh Asset Management fully exited MorphoSys AG American Depositary Shares in Q4 2024, selling an estimated $2.34M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2024.
  • Hennion & Walsh Asset Management opened 52 new positions and closed 67 in Q4 2024.
  • Hennion & Walsh Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.21B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.